This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Health Stock Short-Squeeze Opportunities

Inverness Medical Innovations (IMA) is a developer and manufacturer of medical diagnostic products for professionals and consumers.

The company's products focus on everything from fertility testing to infectious disease diagnostics, in addition to a line of vitamins and nutritional supplements.

And while the company's short ratio currently sits at a high 18.7%, Inverness Medical's novel business model could be the key to pushing ahead of competitors. Thanks to business exposure provided by an acquisition, the company plans to combine its diagnostic devices with health-management services in a way that maximizes the profitability of each. As the company continues to integrate its health-management acquisitions into its core diagnostic business, expect to see margins and overall profitability increase.

For the rest of this week's short-squeeze opportunities, including Virtual Radiologic (VRAD) and Dr. Reddy's Laboratories (RDY - Get Report), check out the Health Stock Short Squeezes portfolio at Stockpickr.

And to find short-squeeze plays of your own, be sure to check out the Stockpickr Answers community for insights and investment ideas.

-- Written by Jonas Elmerraji in Baltimore.

At the time of publication, author had no positions in stocks mentioned.

Jonas Elmerraji is the editor and portfolio manager of the Rhino Stock Report, a free investment advisory that returned 15% in 2008. He is a contributor to numerous financial outlets, including Forbes and Investopedia, and has been featured in Investor's Business Daily, in Consumer's Digest and on MSNBC.com.
4 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
DANOY $14.00 -0.28%
LWAY $18.90 -6.20%
RDY $57.41 1.10%
UTHR $183.79 0.65%
AAPL $132.58 0.91%

Markets

DOW 18,233.42 -52.32 -0.29%
S&P 500 2,128.73 -2.09 -0.10%
NASDAQ 5,095.8720 +5.0780 0.10%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs